# Enantioselective Olefin 1,2-Arylamination Catalyzed by a Planar Chiral Indenyl-Rhodium(III) Complex

**Authors:** Patrick Gross, Hyoju Choi, Wesley A. Pullara, Hoyoung Im, Khang Ung, Seunguk Kang, Mu-Hyun Baik, Simon B. Blakey

PMC · DOI: 10.1021/acscatal.5c07589 · ACS Catalysis · 2026-01-16

## TL;DR

A new method for creating chiral aminated compounds using a rhodium catalyst, which could be useful in drug development.

## Contribution

A novel enantioselective 1,2-arylamination method using a planar chiral indenyl-Rh(III) complex for synthesizing biologically relevant molecules.

## Key findings

- The chiral indenyl ligand's electronic asymmetry enhances catalytic activity over cyclopentadienyl-based analogs.
- The N-protecting group on hydroxylamine influences the reaction pathway, distinguishing it from aziridination strategies.
- The method enables efficient synthesis of diverse 2-aminotetralin scaffolds and amino-substituted carbospirocycles.

## Abstract

We report an enantioselective 1,2-arylamination of unactivated
alkenes catalyzed by a chiral indenyl-Rh­(III) complex using Troc-protected
hydroxylamine derivatives. This method enables efficient access to
structurally diverse 2-aminotetralin scaffolds and amino-substituted
carbospirocycles via a 6-endo cyclization involving electrophilic
aromatic substitution (EAS). Experimental and computational studies
reveal that the electronic asymmetry of the chiral indenyl ligand
plays a pivotal role in enhancing catalytic activity compared to cyclopentadienyl-based
analogs. Furthermore, the identity of the N-protecting group on hydroxylamine
significantly influences the reaction pathway, distinguishing this
transformation from previously reported aziridination strategies.
The synthetic utility and versatility of this catalytic system are
further demonstrated through streamlined syntheses of biologically
relevant molecules, highlighting its strong potential for applications
in medicinal chemistry.

## Linked entities

- **Chemicals:** 2-aminotetralin (PubChem CID 34677)

## Full-text entities

- **Genes:** HTR7 (5-hydroxytryptamine receptor 7) [NCBI Gene 3363] {aka 5-HT7}, CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}, HTR1A (5-hydroxytryptamine receptor 1A) [NCBI Gene 3350] {aka 5-HT-1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1, G-21}
- **Diseases:** depression (MESH:D003866), neurological disorders (MESH:D009461), addiction (MESH:D019966), cancer (MESH:D009369), Parkinson's disease (MESH:D010300)
- **Chemicals:** indole (MESH:C030374), ether (MESH:D004986), 2-naphthol (MESH:C028405), azepine (MESH:D001381), tetralin (MESH:C095210), H (MESH:D006859), nitrene (MESH:C017621), R  A8 (MESH:D004176), aziridines (MESH:D001388), ( S )-8 (MESH:C039415), dibromomethane (MESH:C027947), R  A7 (MESH:C058422), amine (MESH:D000588), beta-tetralones (MESH:C009423), carbamate (MESH:D002219), ( R ) (MESH:D001120), phenethylamine (MESH:C029261), hydroxylamine (MESH:D019811), 8-OH-DPAT (MESH:D017371), hexanes (MESH:D006586), aTMS (MESH:C020809), deuterium (MESH:D003903), AcOH (-), S (MESH:D013455), 2-phenylpropionic acid (MESH:C013025), phenethylamines (MESH:D010627), Rh (MESH:D012238), isopropanol (MESH:D019840), acetic acid (MESH:D019342), Olefin (MESH:D000475), TBS (MESH:D013725), propionic acid (MESH:C029658), 2-Aminotetralins (MESH:C006561), aziridine (MESH:C033132), C (MESH:D002244), N2 (MESH:D009584), formic acid (MESH:C030544), bromine (MESH:D001966), benzofuran (MESH:C105430), TFE (MESH:D011138), Zn (MESH:D015032), oxygen (MESH:D010100), Methanol (MESH:D000432)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930352/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930352/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930352/full.md

---
Source: https://tomesphere.com/paper/PMC12930352